Cross-sectional study of care, socio-economic status and complications in young French patients with type 1 diabetes mellitus

Diabetes and Metabolism

Volumn 31, Issue 1, 2005, Pages 41-46

  Lievre M ^a   Marre, M ^a   Robert, J J ^a   Charpentier, G ^a   Iannascoli, F ^a   Passa, P ^a  

^a NONE

Author keywords

Complications; Cross sectional study; Socio economic status; Treatment; Type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; FOLLOW UP; FRANCE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; KETOACIDOSIS; LEG DISEASE; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; MICROALBUMINURIA; PATIENT CARE; PREVALENCE; SCHOOL CHILD; SOCIOECONOMICS;

EID: 14744281814     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70165-9     Document Type: Article

References (22)

1. Passa P. Diabetes trends in Europe. Diabetes Metab Res Rev, 2002, 18, S3-S8.
2. Ricordeau P, Weill A, Vallier N, Bourrel R, Fender P, Allemand H. L'épidémiologie du diabète en France métropolitaine. Diabetes Metab, 2000, 26, S11-S24.
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993, 329, 977-86.
4. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type I diabetes four years after a trial of intensive therapy. N Engl J Med, 2000, 342, 381-9.
5. Lewis EJ, Hunsicker LG, Bain RP, Rohde RR. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med, 1993, 329, 1456-62.
6. Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens, 1999, 17, 151-83.
7. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care, 2002, 25, S33-S49.
8. Batty GD, Leon DA. Socio-economic position and coronary heart disease risk factors in children and young people. Evidence from UK epidemiological studies. Eur J Public Health, 2002, 12, 263-72.
9. Eachus J, Williams M, Chan P, et al. Deprivation and cause specific morbidity; evidence from the Somerset and Avon survey of health. BMJ, 1996, 312, 287-92.
10. Weng C, Coppini DV, Sonksen PH. Geographic and social factors are related to increased morbidity and mortality rates in diabetic patients. Diabet Med, 2000, 17, 612-7.
11. Edwards R, Burns JA, Mc Elduff P, Young RJ, New JP. Variations in process and outcomes of diabetes care by socio-economic status in Salford, UK. Diabetologia, 2003, 46, 750-9.
12. Charbonnel B, Balarac N, Cazeneuve B, Augendre-Ferrante B, Le Thaï F, Drouin P. Which are the insulin treatment regimens used in France? The Schema survey. Diabetes Metab, 2000, 27, 591-7.
13. Tubiana-Rufi N, Moret L, Chwalow J, Czernichow P et le groupe collaborative PEDIAB. Etat de santé et facteurs liés au contrôle glycémique chez 165 enfants atteints de diabète insulinodépendant âgés de 7 à 13 ans. Arch Pédiatr, 1994, 1, 982-90.
14. Mortensen HB, Hougaard P, for the Hvidore Study Group on Childhood Diabetes. Comparison of metabolic control in a cross-sectional study of 2.873 children and adolescents with IDDM from 18 countries. Diabetes Care, 1997, 20, 714-20.
15. Diabetes Control and Complications Trial research group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediat, 1994, 125, 177-88.
16. UK Prospective Diabetes Study (UKPDS) group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 1998, 352, 837-53.
17. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ, 1998, 17, 703-13.
18. Kasiske BL, Kalil RSN, Ma JZ, Liao M, Keane WF. Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med, 1993, 118, 129-38.
19. The ACE inhibitors in diabetic nephropathy trialist group. Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data. Ann Intern Med, 2001, 134, 370-9.
20. Chaturvedi N, Stephenson JM, Fuller JH. The relationship between socioeconomic status and diabetes control and complications in the EURODIAB IDDM complications study. Diabetes Care, 1996, 19, 423-30.
21. Larsson D, Lager I. Nilsson PM. Socio-economic characteristics and quality of life in diabetes mellitus - relation to metabolic control. Scand J Public Health, 1999, 27, 101-5.
22. Fored CM, Ejerblad E, Fryzec JP, et al. Socio-economic status and chronic renal failure: a population-based case-control study in Sweden. Nephrol Dial Transplant, 2003, 18, 82-8.